Pharmaceutical Technology, Nov 1, 2010 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Nov 1, 2010
Online Exclusives
Drug Targeting by Diagnostic Ultrasound Contrast
By Steliyan Tinkov , Conrad Coester , Raffi Bekeredjian , Gerhard Winter
Microbubbles can temporarily open many biological barriers for polar molecules, macromolecules, and particles. Scientists have brought well-known contrast agents back to the laboratory and redesigned them as drug carriers. This article is part of a special Drug Delivery issue.
Articles
Sustained-Release Injectable Drug Delivery
By Yun-Seok Rhee , Chun-Woong Park , Patrick P. DeLuca , Heidi M. Mansour
A review on the current status of long-acting injectables, including commercially marketed products. This article is part of a special Drug Delivery issue.
Transdermal Delivery of Vaccines and Therapeutic Proteins
By Kris J. Hansen
The author reviews advances in technology that may soon allow transdermal delivery of two of the fastest growing drug classes on the pharmaceutical market. This article is part of a special Drug Delivery issue.
Considerations and Approaches for Filling Dry-Powder Inhalers
By Craig J. Davies Cutting
The author reviews key considerations for formulating powders for use in inhalers. This article is part of a special Drug Delivery issue.
Capsule-in-Capsule Technology
By W.J. Bowtle
The author outlines how to choose carriers and capsule shells according to dosage requirements and intended use. This article is part of a special Drug Delivery issue.
Melt Extrusion: Shaping Drug Delivery in the 21st Century
By James C. DiNunzio , Charlie Martin , Feng Zhang
The authors provde a review of melt extrusion's evolution and applications in the pharmaceutical industry. This article is part of a special Drug Delivery issue.
Minitablets Coated in a Solid-Wall Pan for Theophylline Sustained-Release Capsules
By Caterina Funaro , Giusi Mondelli , Nadia Passerini , Beatrice Albertini
The authors describe an alternative approach to compressing and coating minitablets for use in a sustained-release, solid oral-dosage form. This article is part of a special Drug Delivery issue.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here